Tap into our extensive network of 4,000+ GI sites, leverage exclusive data from 150+ central imaging projects, and benefit from our team of medical and operational experts for swift study startup and accelerated patient recruitment.
We excel in expediting GI studies ahead of our competitors. through quicker study initiation and patient enrollment, surpassing the industry standard.
Our commitment to cutting-edge technology and methodologies is key to our site network depth, retention, and enrolment success.
We deliver actionable insights, reducing time to market for our clients.
Driving health breakthroughs with a specialized focus on gastrointestinal therapeutics, Alimentiv stands at the forefront of innovation. We are dedicated to advancing research, accelerating clinical trials, and delivering actionable insights to redefine the future of GI healthcare.
Pioneering advancements in gastrointestinal therapeutics, Alimentiv leads with innovation. Regardless of the stage or complexity of your project, our team can assist by providing streamlined clinical development solutions for your projects. From protocol design to recruitment, our experts can effectively address regulatory requirements, patient and site recruitment challenges, protocol designs and procedures, and patient-reported outcomes. Furthermore, our tailored problem-solving approach can assist you in managing costs and mitigating risks inherent to your clinical projects.
Vuyyuru SK, Solitano V, Singh S, Hanzel J, Macdonald JK, Danese S, Peyrin Biroulet L, Ma C, Jairath V. Scoring Indices for Perianal Fistulising Crohn's Disease: A Systematic Review. J Crohns Colitis. 2024 Jun 3;18(6):836-850. doi: 10.1093/ecco-jcc/jjad214. PMID: 38126903.
If you’ve missed some of our lecture presentations and poster sessions, reach out for more information....
London, Ontario, Canada, May 13, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce two lecture presentations and six poster presentations at the Digestive Disease...
Speak to a member
of our expert team
